Our New Innovation – Black Pearl Technology. Inherit from Autologous Conditioned Serum (ACS).
“In RCT, our dream is to overcome global medical challenges with innate human potentials and our innovation, Black Pearl Technology.”
- Five years of Clinical and Laboratory research
- treating more than 1000 patients,
- WIPO patent for Black Pearl Technology
